Regulations.gov document
Attachment 3 - "Product Description - Ganciclovir Sodium Injection 50 mg/mL" [PharmaForce…
Supporting & Related Material · FDA-2009-P-0222 · posted May 22, 2009
Key facts
| Document ID | FDA-2009-P-0222-0003 |
|---|---|
| Title | Attachment 3 - "Product Description - Ganciclovir Sodium Injection 50 mg/mL" [PharmaForce, Inc. - Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2009-P-0222 |
| Posted | May 22, 2009 |
| Effective date | May 14, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: